DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to GM-CSF
Related studies linked through entity extraction aliases.
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
- Status
- RECRUITING
- Phase
- PHASE1
Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy
- Status
- RECRUITING
- Phase
- PHASE2
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)
- Status
- UNKNOWN
- Phase
- PHASE2
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.
- Status
- UNKNOWN
- Phase
- PHASE2
ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC
- Status
- UNKNOWN
- Phase
- PHASE2
GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS
- Status
- COMPLETED
- Phase
- PHASE3
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.
- Status
- WITHDRAWN
- Phase
- PHASE2
Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)
- Status
- UNKNOWN
- Phase
- PHASE2
IBI188 Combination Therapy in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1